PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
25.26
+0.46 (1.85%)
May 7, 2026, 10:53 AM EDT - Market open
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 9 analysts that cover PROCEPT BioRobotics stock have a consensus rating of "Buy" and an average price target of $36.22, which forecasts a 43.39% increase in the stock price over the next year. The lowest target is $20 and the highest is $62.
Price Target: $36.22 (+43.39%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $28 → $35 | Buy | Reiterates | $28 → $35 | +38.56% | Apr 30, 2026 |
| Baird | Baird | Hold Initiates $30 | Hold | Initiates | $30 | +18.76% | Mar 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $47 → $30 | Strong Buy | Maintains | $47 → $30 | +18.76% | Mar 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $55 → $30 | Buy | Maintains | $55 → $30 | +18.76% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $50 → $34 | Strong Buy | Maintains | $50 → $34 | +34.60% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
407.04M
from 308.05M
Increased by 32.13%
Revenue Next Year
502.51M
from 407.04M
Increased by 23.45%
EPS This Year
-1.55
from -1.72
EPS Next Year
-0.93
from -1.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 424.3M | 529.5M | |||
| Avg | 407.0M | 502.5M | |||
| Low | 384.9M | 467.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.7% | 30.1% | |||
| Avg | 32.1% | 23.5% | |||
| Low | 25.0% | 14.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.43 | -0.59 | |||
| Avg | -1.55 | -0.93 | |||
| Low | -1.62 | -1.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.